Parse Biosciences Launches CRISPR Detect
Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions announced today the launch of CRISPR Detect enabling single cell pooled CRISPR screens at unprecedented scale.
Stay updated with breaking news from Evercode Whole Transcriptome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions announced today the launch of CRISPR Detect enabling single cell pooled CRISPR screens at unprecedented scale.
Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions today announced an agreement with Israelbased Ornat Biochemicals and Laboratory Equipment to extend Parses reach in the Middle East.
On Wednesday, 10X Genomics, Inc. filed a complaint in the District of Delaware against Parse Biosciences, Inc. and the Board of Trustees of Leland
Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall ...
Company to commercialize and create single-cell multi-omics products Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series